Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial (Q37521237)
Jump to navigation
Jump to search
scientific article published on 09 July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial |
scientific article published on 09 July 2013 |
Statements
Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial (English)
Daniel S Berman
Leslee J Shaw
John A Spertus
William E Boden
William S Weintraub
Merril Knudtson
David J Maron
David J Cohen
Pam Hartigan
Mihaela Aslan
Marcin Dada
G B John Mancini
Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Investigators and Coordinators
1 reference
1 reference
1 reference
1 reference